These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 2578396)

  • 21. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells.
    Sterkers G; Henin Y; Kalil J; Bagot M; Levy JP
    J Immunol; 1983 Dec; 131(6):2735-40. PubMed ID: 6227663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
    Diedrichs M; Schendel DJ
    J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-specific human T cells. Epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes-associated haplotype.
    Miller GG; Pollack MS; Nell LJ; Thomas JW
    J Immunol; 1987 Dec; 139(11):3622-9. PubMed ID: 2445817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class II restriction of T helper cell response to cytomegalovirus (CMV). I. Immunogenetic control of restriction.
    Gehrz RC; Fuad S; Liu YN; Bach FH
    J Immunol; 1987 May; 138(10):3145-51. PubMed ID: 2437182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
    Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
    Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes.
    Spits H; Borst J; Giphart M; Coligan J; Terhorst C; De Vries JE
    Eur J Immunol; 1984 Apr; 14(4):299-304. PubMed ID: 6609821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth of antigen specific, HLA restricted T lymphocyte clones from cerebrospinal fluid.
    Fleischer B; Bogdahn U
    Clin Exp Immunol; 1983 Apr; 52(1):38-44. PubMed ID: 6190597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen presentation by Hodgkin's disease cells.
    Fisher RI; Cossman J; Diehl V; Volkman DJ
    J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro effects of solubilized HLA-DR--role in immunoregulation?
    Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W
    Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloned human T lymphocytes with lymphostimulatory capacity preferentially activate suppressor cells.
    Pawelec G; Schneider EM; Wernet P
    Eur J Immunol; 1984 Apr; 14(4):335-40. PubMed ID: 6233155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell clones restricted to "hybrid" HLA-D antigens?
    Hansen GS; Svejgaard A; Claësson MH
    J Immunol; 1982 Jun; 128(6):2497-9. PubMed ID: 6176640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-nonself discrimination and repertoire selection of human T cells differentiated in an HLA-semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency.
    Knobloch C; Goldmann SF; Friedrich W
    Eur J Immunol; 1991 Oct; 21(10):2479-87. PubMed ID: 1833204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
    Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
    J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional studies of HLA-DR restricted antigen recognition by human helper T lymphocyte clones by using transfected murine cell lines.
    Lechler RI; Bal V; Rothbard JB; Germain RN; Sekaly R; Long EO; Lamb J
    J Immunol; 1988 Nov; 141(9):3003-9. PubMed ID: 2459238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA class II restriction governing cell cooperation between antigen-specific helper T lymphocytes, B lymphocytes and monocytes for in vitro antibody production to influenza virus.
    Fischer A; Sterkers G; Charron D; Durandy A
    Eur J Immunol; 1985 Jun; 15(6):620-6. PubMed ID: 3159585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.